Study Summary
This trial is testing a new, more effective radiation treatment for prostate cancer. The hope is that it will improve cancer control and quality of life by reducing damage to nearby organs.
- Prostate Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 10 Secondary · Reporting Duration: Up to 5.25 years (post-treatment)
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
LEAD RT Group
1 of 2
HEIGHT RT Group
1 of 2
Experimental Treatment
164 Total Participants · 2 Treatment Groups
Primary Treatment: HEIGHT RT · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 35 - 85 · Male Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Information/NLM/NIH, NCBI. 2017. “Gprobe”. GitHub repository. https://github.com/ncbi/gprobe.
- Alan Pollack, MD, PhD 2015. "Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02307058.
Frequently Asked Questions
What is the current maximum capacity for enrollment in this clinical trial?
"Affirmative. Per the clinicaltrials.gov page, this research study is actively accepting participants from one site with a total of 164 required individuals since February 5th 2015 when it was initially advertised and last amended on May 23rd 2022." - Anonymous Online Contributor
Is submission of applications to participate in this study still feasible?
"Affirmative. Clinicaltrials.gov records suggest that this clinical trial, initially posted on February 5th 2015, is currently looking for volunteers; 164 participants are needed from a single medical centre." - Anonymous Online Contributor
Am I eligible to participate in this investigation?
"This research project is enrolling 164 individuals with prostate cancer aged 35 and 85. To qualify, they must have a Gleason score between 6-10, start their treatment no later than 3 months before signing the consent form, initiate the therapy prior to beginning radiotherapy therapies, and complete the program within 30 months total." - Anonymous Online Contributor
Is the age cap for participation in this experimental research higher than 40 years?
"This trial is available for patients aged 35 to 85, but there are separate trials intended for minors (76) and seniors (1315)." - Anonymous Online Contributor